| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.76B | 49.34B | 47.86B | 45.29B | 40.88B | 36.59B |
| Gross Profit | 10.20B | 9.93B | 9.86B | 7.42B | 7.29B | 6.73B |
| EBITDA | 6.07B | 6.32B | 7.20B | 4.46B | 4.45B | 3.73B |
| Net Income | 3.39B | 3.38B | 3.02B | 816.45M | 831.83M | 769.47M |
Balance Sheet | ||||||
| Total Assets | 59.82B | 61.13B | 57.29B | 51.43B | 47.64B | 43.88B |
| Cash, Cash Equivalents and Short-Term Investments | 18.53B | 20.58B | 18.19B | 13.41B | 11.45B | 11.29B |
| Total Debt | 3.08B | 2.80B | 3.00B | 3.20B | 2.90B | 3.11B |
| Total Liabilities | 14.13B | 14.16B | 15.01B | 14.48B | 13.95B | 12.30B |
| Stockholders Equity | 42.96B | 44.18B | 39.93B | 34.90B | 32.02B | 30.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.11B | 5.10B | 1.28B | 351.74M | 5.87M |
| Operating Cash Flow | 0.00 | 5.07B | 7.71B | 3.15B | 2.61B | 2.84B |
| Investing Cash Flow | 0.00 | -3.79B | -3.62B | -2.30B | -2.13B | -2.82B |
| Financing Cash Flow | 0.00 | -1.54B | -913.69M | -168.84M | -718.90M | 539.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥435.63B | 10.54 | 9.34% | 4.27% | -0.48% | -35.29% | |
79 Outperform | ¥25.87B | 6.38 | ― | 5.21% | 0.91% | 100.31% | |
79 Outperform | ¥408.97B | 12.16 | 9.65% | 3.91% | 0.87% | 16.71% | |
76 Outperform | ¥527.48B | 20.36 | 6.52% | 1.82% | 3.25% | -11.31% | |
74 Outperform | ¥180.92B | 17.43 | ― | 2.84% | 6.06% | 19.76% | |
65 Neutral | ¥419.23B | 12.96 | 8.14% | 2.61% | -1.45% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |